Venom immunotherapy and pregnancy

Krzysztof Pałgan; Magdalena Żbikowska-Götz; Elżbieta Chrzaniecka; Zbigniew Bartuzi

doi:10.5114/ada.2018.73168

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2018
vol. 35

Send email

Copy url:

abstract:

Original paper

Venom immunotherapy and pregnancy

Krzysztof Pałgan

,

Magdalena Żbikowska-Götz

,

Elżbieta Chrzaniecka

,

Zbigniew Bartuzi

Adv Dermatol Allergol 2018; XXXV (1): 90-92

DOI: https://doi.org/10.5114/ada.2018.73168

Online publish date: 2018/02/20

View full text Get citation

Introduction: The efficiency of venom immunotherapy (VIT) has been well documented by many studies. However, the most important for VIT is safety, particularly for a pregnant woman and a fetus.

Aim: To establish the influence of continuation of VIT on pregnant women and offspring.

Material and methods: The 6 women became pregnant during a specific immunotherapy. We retrospectively analyzed the influence of the immunotherapy on any complications for the pregnant women and their infants.

Results: Of the 6 patients who participated in this study, four had hyperemesis gravidarum, nausea, and heartburn, and two of them had gestational diabetes mellitus symptoms, typical of pregnancy. The observation indicated that VIT was safe for the pregnant women and their offspring.

Conclusions: The VIT is an appropriate therapeutic method for most patients with severe anaphylactic reactions after a hymenoptera sting. The observation indicated that VIT is safe for pregnant women and for their infants.

keywords:

Venom immunotherapy and pregnancy

Krzysztof Pałgan , Magdalena Żbikowska-Götz , Elżbieta Chrzaniecka , Zbigniew Bartuzi

venom immunotherapy, pregnancy

Krzysztof Pałgan

,

Magdalena Żbikowska-Götz

,

Elżbieta Chrzaniecka

,

Zbigniew Bartuzi